|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Selling, general and administrative | |||||
| Research and development | |||||
| Investigation, restatement and related | |||||
| Amortization of intangible assets | |||||
| Impairment of intangible assets | |||||
| Operating income | |||||
| Other income (expense), net | |||||
| Interest income (expense), net | |||||
| Other expense, net | |||||
| Income from continuing operations before income tax | |||||
| Income tax provision (expense) benefit from continuing operations | |||||
| Net income from continuing operations | |||||
| Income (loss) from discontinued operations, net of tax | |||||
| Net income | |||||
| Net income available to common stockholders from continuing operations | |||||
| Basic net income (loss) per common share: | |||||
| Continuing operations - basic (in dollars per share) | |||||
| Discontinued operations - basic (in dollars per share) | |||||
| Basic net income per common share (in dollars per share) | |||||
| Diluted net income (loss) per common share: | |||||
| Continuing operations (in dollars per share) | |||||
| Discontinued operations (in dollars per share) | |||||
| Diluted net income (loss) per common share (in dollars per share) | |||||
| Weighted average shares outstanding - basic (in shares) | |||||
| Weighted average shares outstanding - diluted (in shares) | |||||
Loading...